SC03 Plating system
DeviceAdjustable carbon fiber sternal plates
NCT Number: NCT07366203
The goal of this clinical trial is to learn if a new medical device (SC03 plates) to close the sternum after a sternotomy in patients that have been operated of a cardiac surgery, is safe and effective. The main question it aims to answer is:
Do patients that have the sternum closed with the SC03 plates present a stable sternum one month after surgery?
Researchers will compare the SC03 plates with stainless steel wires (current standard of care to close the sternum).
Participants will:
* be implanted with the SC03 or stainless steel wires. * visit the clinic one month and six months after surgery * Keep a diary of their symptoms and analgesia use
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Adjustable carbon fiber sternal plates
Nonabsorbable, sterile, surgical sutures used in sternal closure
Time frame: 1 month post operatively
Sternal stability measured by clinical assessment using the sternal instability scale (SIS), with grades 0 to 3 where 0 is "Clinically stable sternum" and 3 is "Completely separated sternum - entire length"
Time frame: Perioperative, 1 month and 6 months postoperatively.
Incidence of Device Deficiencies, AE and SAE with a possible, probable or causal relationship with the device or the procedure.
Time frame: 1 month and 6 months postoperatively
Incidence and cause of surgical reinterventions
Time frame: First month and six months postoperatively.
Incidence of sternal superficial and deep wound infections (mediastinitis)
Time frame: First month and six months postoperatively
Incidence of sternal dehiscence (without infection)
Time frame: Surgery
Duration of sternotomy closure procedure (minutes)
Time frame: Surgery
Surgeon-reported ease of use and satisfaction score (Likert Scale, from 1 to 5)
Time frame: Baseline, 7 days, 1 month and 6 months postoperatively.
Patient-reported sternal pain at rest and during forced cough, measured by Numerical Rating Scale (0-10)
Time frame: Day 7, 1 month and 6 months postoperatively
Type and cumulative dose of analgesia (total morphine milligram equivalents (MME))
Time frame: 12 hours postoperatively
Chest tube drainage (mL)
Time frame: 48 hours after surgery
Haemoglobin drop (g/dL)
Time frame: 48 hour after surgery
Number of administered perioperative blood transfusions of packed red blood cells
Time frame: from surgery date to Intensive care unit discharge date (up to 150 days)]
Intensive Care Unit stay duration (hours)
Time frame: from surgery date to hospital discharge date (up to 150 days)
hospitalization duration (days)
Time frame: 7 days and 6 months postoperatively
Sternal stability clinically assessed with the sternal instability scale (from 0 to 3)
Time frame: Before surgery, one month and 6 months postoperatively
Patients will assess their upper limbs functional capacity using the Upper Limb functional index (ULFI-Sp)
Time frame: Before surgery, one month and 6 months postoperatively
Patients will complete the EQ-5D-5L questionnaire
Time frame: 1 month after surgery
Presence of visible bulging related to the sternal closure method on the sternotomy area
Time frame: Baseline, day 7 and 1 month postoperatively
Pulmonary function (FVC, FEV1 and FEV1/FVC) measured by spirometry
Contact information is provided by the study sponsor or research team.
NEOS Surgery
Industry
Clinical Investigation to Evaluate the Use of Adjustable Carbon Fiber Sternal Plates for Sternotomy Closure
Acronym: FIX IT ALL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07013240
Cicatrix, Collagen Diseases
Bordeaux, France
View Trial DetailsNCT06681272
Cardiac Surgery, Chronic Pain Post-Procedural
Bron, France
View Trial Details